Epidemiology and Genotypes Circulating of Respiratory Syncytial Virus in Cote d’Ivoire, 2022-2023

Herve A. Kadjo¹, Venance Kouakou¹, Yakoura Karidja Ouattara^1, , Daouda Coulibaly², Anderson Ngattia², Maxime Diane³, Nguessan Konan², Adagba Marius¹, Edgard Adjogoua¹ and Meite Syndou⁴

¹Department of Epidemic Viruses, Pasteur Institute of Côte d'Ivoire

²Epidemiological Surveillance Service, National Institute of Public Hygiene

³Biological Resources Center, Pasteur Institute of Côte d'Ivoire

⁴Molecular Biology Platform, Pasteur Institute of Côte d'Ivoire

Cite this paper:
Herve A. Kadjo, Venance Kouakou, Yakoura Karidja Ouattara, Daouda Coulibaly, Anderson Ngattia, Maxime Diane, Nguessan Konan, Adagba Marius, Edgard Adjogoua and Meite Syndou. Epidemiology and Genotypes Circulating of Respiratory Syncytial Virus in Cote d’Ivoire, 2022-2023. American Journal of Microbiological Research. 2025; 13(3):58-66. doi: 10.12691/ajmr-13-3-4

Abstract

The burden of human respiratory syncytial virus (RSV) continues to grow worldwide, particularly among the youngest segment of the population. This study aimed to describe the epidemiological and clinical characteristics of RSV circulating in Côte d'Ivoire between 2022 and 2023, and to characterize the genotypes in circulation. A total of 8,317 patients presenting with severe acute respiratory infections (SARI) or influenza-like illness (ILI) were enrolled in the study. Respiratory specimens were tested for RSV using real-time PCR. Whole-genome sequencing and phylogenetic analyses were conducted to identify circulating genotypes. Among the enrolled patients, 3,208 (38.6%) had SARI and 5,109 (61.4%) had ILI. The overall RSV positivity rate was 5.6%. The proportion of females testing positive was significantly higher than that of males (5.8% vs. 5.4%, p = 0.007). The median age of RSV-positive individuals was 1 year (interquartile range [IQR]: 0–2 years). No significant difference in RSV positivity was observed between SARI and ILI cases (p = 0.870). In terms of seasonality, RSV positivity peaked in August, reaching 12%. Among RSV-positive cases, 81.4% were RSV group B and 18.6% were RSV group A. Phylogenetic analysis revealed that most RSV-A strains belonged to clade A.D.5.1, while RSV-B strains were predominantly of clade B.D.E.1. RSV circulation in Côte d'Ivoire exhibited a clear seasonal pattern, with peak activity during the rainy season. The most affected population was children under two years of age. Molecular analysis indicated that clade B.D.E.1 has replaced B.D.4.1.1 as the dominant RSV-B lineage. Continued genomic surveillance is essential to monitor RSV evolution and inform future prevention strategies, including vaccine development and immunization policies.

Keywords:
Epidemiology Genotypes Circulating Respiratory syncytial virus

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Wang, X., Li, Y., Shi, T., Bont, L.J., Chu, H.Y., Zar, H.J., Singh, B.W., Yiming, M., Bingbing, C., Sharland, E., Riley, D.R., Jikui, D.J.F.A., Heikkinen, T., Jones, M.H., Johannes, G.L., Joško, M., Asuncion, M., Marta, C.N., Bernhard, R., Ashish, S., Yeo, K.T., Eric, A.F., Simões, Harish, N. and Eurico, A. “ Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data”.The Lancet 403 (10433): 1241‑53.
[2]	Jain, H., Schweitzer, J.W. and Justice, N.A. “Respiratory Syncytial Virus Infection in Children”. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; [cité 31 janv 2025]. Disponible sur: . 2025.
[3]	Obando-Pacheco, P., Justicia-Grande, A.J., Rivero-Calle, I., Rodríguez-Tenreiro, C., Sly, P., Ramilo, O. and Asunción, M. “Respiratory Syncytial Virus Seasonality: A Global Overview”. Journal Infection Diseases, 217(9):1356‑64. April 2018.
[4]	Pangesti, K.N.A., El, Ghany, M.A., Kesson, A.M., Hill-Cawthorne, G.A. “Respiratory syncytial virus in the Western Pacific Region asystematic review and meta-analysis”. Journal of Global Health, 9(2): 020431.
[5]	Chadha, M., Hirve, S., Bancej, C., Barr, I., Baumeister, E., Caetano, B. and Malinee, C.“Human respiratory syncytial virus and influenza seasonality patterns-Early findings from the WHO global respiratory syncytial virus surveillance”. Influenza and Other Respiratory Viruses, 14 (6): 638-46.
[6]	Kampmann, B., Madhi, S.A., Munjal, I., Simões, E.A.F., Pahud, B.A., Llapur, C. and Baker, J.“Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants”.The New England Journal of Medicine 388 (16): 1451‑64.
[7]	Ison, M.G., Papi, A., Athan, E., Feldman, R.G., Langley, J.M., Lee, D.G. and Leroux-Roelset “Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons”.Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 78 (6): 1732‑44.
[8]	Kelleher, K., Subramaniam, N. and Drysdale, S.B. “The recent landscape of RSV vaccine research”. Therapeutic Advances in Vaccines and Immunotherapy, 13 (25) 151-355.
[9]	Piedimonte and Giovanni. “RSV Infections: State of the Art”. Cleveland Clinic Journal of Medicine 82 (11 suppl 1): S13‑18.
[10]	Salimi, V., Viegas, M., Trento., A, Agoti, C.N., Anderson, L.J., Avadhanula, V. and Justin, B. “Proposal for Human Respiratory Syncytial Virus Nomenclature below the Species Level”. Emerging Infectious Diseases 27 (6): 1‑9.
[11]	Peret, T.C., Hall, C.B., Schnabel, K.C., Golub, J.A. and Anderson, L.J.“Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community”. The Journal of General Virology.79 (9): 2221‑29.
[12]	Goya, Stephanie, Christopher, R., Richard, A, Neher, Adam, M., Ammar, A., Angie, S. H. and Anne, V.G. “Standardized Phylogenetic Classification of Human Respiratory Syncytial Virus Below the Subgroup Level”. Emerging Infectious Diseases 30 (8).
[13]	Pneumonia Etiology Research for Child Health (PERCH) Study Group.“Causes of Severe Pneumonia Requiring Hospital Admission in Children without HIV Infection from Africa and Asia: The PERCH Multi-Country Case-Control Study”. Lancet (London, England) 394 (10200): 757‑79.
[14]	Kadjo, H.A., Adjogoua, E., Dia. N., Adagba, M., Abdoulaye, O., Daniel, S. and Bertin, K. “Detection of non-influenza viruses in acute respiratory infections in children nunder five-year-old in cote d’ivoire (january - december 2013)”. ». African Journal of Infectious Diseases 12 (2): 78‑88.
[15]	Kouakou, V., Kadjo, H., Oulo, N.A., N’guessan, F.D. and N’Douba, A. “Surveillance of Respiratory Syncytial Virus in Children Aged 0-5 years in Côte d’Ivoire”. American Journal of BioScience 9 (6): 185‑91.
[16]	Tang, Y., Dang, X., Lv, M., Norris, S.L., Chen, Y., Ren, L. and Enmei, L. “Changes in the prevalence of respiratory pathogens in children due to the COVID-19 pandemic : A systematic review and meta-analysis”. The Journal of Infection 86 (2): 154‑225.
[17]	Chuang, Y.C., Lin, K.P., Wang, L.A., Yeh, T.K. and Liu, P.Y. “The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection”. Infection and Drug Resistance 16 (janvier): 661‑75.
[18]	Bents, S., Viboud, C., Grenfell, B., Hogan, A., Tempia, S., Gottberg, A.V., Jocelyn, M., Sibongile, W., Cheryl, C. and Rachel, B.’ The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa”. Cold Spring Harbor Laboratory. [cité 29 mars 2025].
[19]	Bardsley, M., Morbey, R.A., Hughes, H.E., Beck, C.R., Watson. C.H., Zhao, H., Joanna, E., Gillian, E.S. and Alex, J.E. “Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance a
[20]	Retrospective observational study. The Lancet Infectious Diseases. 23 (1): 56‑66.
[21]	Vianna,L.A., Siqueira, M.M., Volpini, L.P.B., Louro, I.D. and Resende, P.C. “Seasonality, molecular epidemiology, and virulence of Respiratory Syncytial Virus (RSV): A perspective into the Brazilian Influenza Surveillance Program”.PloS One 16 (5): e0251361.
[22]	Drunen, V. L.S., Sylvia, V. and Watkiss, E.R. “Pathogenesis of respiratory syncytial virus”. Current Opinion in Virology 2 (3): 300‑305.
[23]	Yu, J., Liu, N., Zhu, Y., Wang, W., Fan, X., Yuan, X., Xu, J., Zheng, B. and Luan, L. “Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections amongelderly people”. BMC Infectious Diseases. 24 (1): 1129.
[24]	Congy-Jolivet, N., Cenac, C., Dellacasagrande, J., Puissant-Lubrano, B., Apoil, P.A., Guedj, K. and Flora, A. “Monocytes are the main source of STING-mediated IFN-α production”. eBioMedicine [Internet].[cité 30 mars 2025];80. Disponible sur: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00228-6/ fulltext. 80 (juin).
[25]	Suryadevara, M., Domachowske, J.B. “Epidemiology and Seasonality of Childhood Respiratory Syncytial Virus Infections in the Tropics”. Viruses 13 (4): 696.
[26]	Korsun, N., Trifonova, I., Madzharova, I., Alexiev, I., Uzunova, I., Ivanov, I., Petar, V. Tatiana, T. and Iva, C. “Resurgence of respiratory syncytial virus with dominance of RSV-B during the 2022–2023 season”. Frontiers in Microbiology. 1376389.
[27]	Zhi, W., Xu, Q., Chen, Z., Jiang, W., Wang, T., Zhou, Y., Yu, H., Yan, Y. and Pan, T.“Respiratory syncytial virus infection in children and its correlation with climatic and environmental factors”. The Journal of International Medical Research 49 (9): 3000605211044593.
[28]	Hall, C.B.E.E. Walsh, K.C., Schnabel, C.E., Long, K.M., McConnochie, S.W., Hildreth, and L.J.A. “Occurrence of Groups A and B of Respiratory Syncytial Virus over 15 Years: Associated Epidemiologic and Clinical Characteristics in Hospitalized and Ambulatory Children”. The Journal of Infectious Diseases 162 (6): 1283‑90.
[29]	White, L.J., J.N. Mandl, M.G.M., Gomes, A.T., Bodley-Tickell, P.A., Cane, P., Perez-Brena, J.C. and Aguilar. “Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models”. Mathematical Biosciences 209 (1): 222‑39.
[30]	Weber, A., Weber, M., and Milligan, P. “Modeling Epidemics Caused by Respiratory Syncytial Virus (RSV)”. Mathematical Biosciences 172 (2): 95‑113.
[31]	LaVerriere, E., Behar, S., Sher-Jan, C., Liang, Y.M., Sagar, M. and Connor, J.H. “Genomic Epidemiology of Respiratory Syncytial Virus in a New England Hospital System”. medRxiv. medRxiv; 2025 [cité 21 avr 2025]. p. 2025.02.21.25322621.
[32]	Yunker, M., Fall, A., Norton, J., Abdullah, O., Villafuerte, D., Pekosz, A., Klein, E. and Mostafa, H. “Genomic Evolution and Surveillance of Respiratory Syncytial Virus during the 2023-2024 Season”. Viruses. 16 (2):161122.
[33]	Tramuto, F., Maida, C.M., Randazzo, G., Guzzetta, V., Santino, A., Li-Muli, R. and Costantino, C. “Whole-Genome Sequencing and Genetic Diversity of Human Respiratory Syncytial Virus in Patients with Influenza-like Illness in Sicily (Italy) from 2017 to 2023”. Viruses 16 (6): 851.
[34]	Evans, D., Kunerth, H., Mumm, E., Namugenyi, S., Plumb, M., Bistodeau, S., Scott, A. and Cunningham. “Genomic Epidemiology of Human Respiratory Syncytial Virus, Minnesota, USA, July 2023-February 2024”. Emerging Infectious Diseases 30 (11): 2414‑18.
[35]	Masson, E.E.M. “Novel imported clades accelerated the RSV surge in Beijing, China, 2023-2024”. Disponible sur: https:// www.em-consulte.com/ article/ 1708000/ novel-imported-clades-accelerated-the-rsv-surge-in. Consulte. [cité 21 April 2025].
[36]	Wei, X., Wang, L., Li, M., Qi, J., Kang, L. and Hu, G. “Novel imported clades accelerated the RSV surge in Beijing, China, 2023-2024”. Journal of Infection 89 (6).